Immune silencing is driven by 9p regional genetic loss dictating immune checkpoint inhibitor resistance - Scott Lippman, MD, UCSD
![Scott Lippman](/sites/g/files/oketem271/files/styles/3_2_480x320/public/media/images/Event-template-1280x720-DS-lippman.png.webp?itok=f-vPjBjq)
Scott Lippman, MD
University of California, San Diego
Director, Moores Cancer Center
Senior Associate Dean and Associate Vice Chancellor, Cancer Research and Care
Distinguished Professor of Medicine
Chugai Pharmaceutical Chair in Cancer Research
Join us in-person or via Zoom.
RSVP HERE!
Lunch is available to in-person attendees.
DGSOM Theme: Cancer Research Theme
Co-sponsored by the UCLA David Geffen School of Medicine Themes
For additional information, please contact:
ctsiseminar@mednet.ucla.edu